Breaking News

How one company is supporting reproductive rights despite looming regulatory uncertainty

Not rendering correctly? View this email as a web page here.

Tebra raises $72M to scale its operating system for independent practices

By Katie Adams Monday, July 11, 2022 7:25 PM

Tebra, a company that sells software to independent physician practices, announced it has raised more than $72 million and reached a valuation greater than $1 billion. The company, which formed last year as a result of a merger between PatientPop and Kareo, will use the funding to advance its platform and scale its sales and marketing teams.

Read more »

Roche pays $55M for late-stage drug for rare kidney disease with no approved treatment

By Frank Vinluan Monday, July 11, 2022 6:54 PM

An Ionis Pharmaceuticals drug has positive Phase 2 results in immunoglobulin A nephropathy, leading Roche to exercise its option to license the rights to the molecule. The pharmaceutical giant gets a contender in the chase to win the first regulatory approval of a therapy for this rare kidney disease.

Read more »

We're in an era experiencing a tectonic shift in foundations of medical imaging

By John Martin Monday, July 11, 2022 3:24 PM

With a window into human body in real-time, next generation of ultrasound devices thwarts challenges of economic efficiency, geographic limits to care and ineffective training.

Read more »

How proactively addressing social determinants of health (SDOH) can drive better outcomes, lower healthcare costs

By Ted Quinn Monday, July 11, 2022 3:07 PM

With proactive outreach by highly trained community health navigators guided by data and leveraging easy-to-use technology, we could get ahead of an individual's needs, design and execute a care plan, and – hopefully – keep them out of the hospital.

Read more »

Vertex builds up pipeline of type 1 diabetes cell therapies with $320M buyout

By Frank Vinluan Monday, July 11, 2022 2:34 PM

Vertex Pharmaceuticals already has a cell therapy candidate for type 1 diabetes but the company says acquiring rival ViaCyte will provide it with complementary assets and technologies. The two companies already share a partner in common: both have therapeutic candidates that use the gene-editing capabilities of CRISPR Therapeutics.

Read more »

Report: Female physicians are much more aware of medicine's gender discrimination than male physicians

By Katie Adams Monday, July 11, 2022 2:25 PM

Gender discrimination is felt much more in women physicians than it is in men, according to a new report. It found that two-thirds of the female physicians have experienced gender discrimination from a medical colleague, and 57% of them have experienced it from a patients. These numbers were 30% and 19%, respectively, for male physicians.

Read more »

   

No comments